Tempus a company founded by Eric Lefkofsky recently has decided to offer doctors from the University of Chicago information that will modify the treatment of breast cancer. The company has clarified that they will examine data from approximately 1000 patients suffering from breast cancer thus the doctors will find it easy discovering forms that will tell the response of the patients. They aim to achieve the best results of treatment through the data that they are using.
The professor of human genetics and medicine Dr. Olufunmilayo Olopade is glad that they have a partnership with Tempus on the prominent task, and he is ready to help the movement o establish the biggest data treatment in breast cancer that is clinically glossed. Tempus specializes in genomic numbering and machine learning to assist doctors in deciding on good treatment and time.Eric Lefkofsky is the CEO and co-founder of Tempus. Tempus is a firm that has developed a system meant to fight cancer. He is also a founding partner of Lightbank which majors in technology investment. Apart from that he is also a chairman and co-founder of Groupon as well as the co-founder of Uptake Technologies. Lefkofsky achieved a Juris Doctor from the University of Michigan Law School and graduated from the University of Michigan.
The Lefkofsky Family Foundation was started by Eric Lefkofsky in the year 2006. He established it with his with Liz, it is a charitable foundation that is responsible for developing creativities that will improve people’s lives in the society. Moreover Eric is also part of the Trustees of Lurie Children’s Hospital and other organizations including World Business Chicago, The Art Institute of Chicago and The Museum of Science and Industry. On the other hand he is the author of Accelerated Disruption as well as an assistant professor at the University of Chicago.